Fortress Biotech, Inc.
FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dā¦ read more
Healthcare
Biotechnology
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$18.88
Price+0.43%
$0.08
1Y
Price
Market Cap
$148.628m
Small
Price/Earnings 3y Avg5y Avg
9.7x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+70.5%
EBITDA Margin+33.2%
Net Profit Margin-34.6%
Free Cash Flow Margin+70.5%
EBITDA Margin+33.2%
Net Profit Margin-34.6%
Free Cash Flow MarginRevenue
$66.161m
+8.0%
1y CAGR-4.0%
3y CAGR-0.5%
5y CAGREarnings
$127.772m
+108.7%
1y CAGR+54.3%
3y CAGR+32.2%
5y CAGREPS
$3.18
+89.2%
1y CAGR+66.4%
3y CAGR+44.1%
5y CAGRBook Value
$202.374m
$356.874m
Assets$154.500m
Liabilities$53.627m
DebtDebt to Assets
15.0%
-1.8x
Debt to EBITDAFree Cash Flow
$157.637m
+30.5%
1y CAGR+28.7%
3y CAGR+12.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company